|
|
 |
SUCROSE DISTEARATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
UREA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
TRIETHYL CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
XANTHAN GUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|